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The primary development of B lymphocytes in the bone marrow can be
divided into two major phases based on the expression of the lineage-specific
molecule, IgM. In the later of the two phases, the progressive expression of IgM
molecules provides a precise identification of phenotypically distinct subsets of B
lymphocyte precursors. This has permitted detailed studies of the population
sizes, proliferation, and functional maturation of precursor cells in mouse bone
marrow (1-11) . Actively proliferative large pre-B cells containing free cyto-
plasmic A heavy chains (cA)' give rise to small pre-B cells, which without further
division mature into B lymphocytes bearing surface p heavy chains (sA) in whole
IgM molecules. The population of newly formed B lymphocytes turns over
rapidly in the bone marrow as the cells acquire the other surface receptors
characteristic of mature B cells and they migrate to peripheral lymphoid tissues
as functional B cells (12-22). In contrast, cells of the earlier phase of B cell
genesis have not been directly characterized. These populations of precursor
cells lack t, heavy chains, but include cells undergoing Ig heavy chain gene
rearrangements. The number and proliferative amplification of such cells would
be influential factors in determining the variety and size of new B cell clones
being generated per unit time and potentially becoming available to the immune
system.
The B cell lineage in mice is associated with a large (220 kD)surface membrane
glycoprotein (23, 24) detected by severalmonoclonal antibodies (mAb), including
the 14.8 clone developed by Kincade et al . (25). The 14.8 mAb binds to all B
lymphocytes, as well as to both small and large pre-B cellsin mouse bone marrow,
but the total number of 14 .8-binding cells exceeds that of the ', chain-bearing
cells (26). Removal of 14.8+ cells leads to temporary deletion of B lymphocyte
production in vitro (11, 25). These findings suggest that mouse bone marrow
contains a population of early B cell precursor cells that bind 14 .8 antibody
before expressing ,u chains. Their proliferative activity in vivo is unknown.
Terminal deoxynucleotidyl transferase (TdT) is an intranuclear enzyme re-
stricted to immature lymphoid cells in the thymic cortex and bone marrow (27-
32) that appears to be involved in generating immunological diversity. In the B
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' Abbreviations used in this paper:
￿
cA, cytoplasmic j chains; Imet, metaphase incidence or index;
NCS, newborncalf serum; stL, surface ju chains; TdT, terminal deoxynucleotidyl transferase; TRITC,
rhodamine isothiocyanate.
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nucleotide sequences, not in the original template sequence, at VJ and DJ
junctions during Ig heavy chain gene rearrangements . The bone marrow of
human subjects and rats contain TdT' cells that exhibit B cell lineage-associated
markers (31, 35-37) . TdT' cells found within mouse bone marrow could thus
be early B lineage precursors during the stage of Ig heavy chain gene rearrange-
ment, but the characteristics of such a TdT+ cell population and its possible
relationship to the B lineage-associated antigen detected by mAb 14.8 are
unclear .
We wondered whether the degree of coexpression of the foregoing cell
markers on individual cells in mouse bone marrow would permit a direct
characterization of early B lymphocyte precursor cells and their properties .
Double immunofluorescence labeling of individual cells for the presence of the
14.8 antigen, TdT, and 1A chains in various combinations has quantitated three
phenotypically distinct cell subsets with characteristic cell size distribution profiles
and, in conjunction with a mitotic arrest technique, has established their normal
proliferative dynamics in vivo . The three cell subsets are proposed to be succes-
sive differentiation steps in a working scheme of primary B lymphocyte produc-
tion in the bone marrow .
Animals
C3H/HeJ male mice were purchased fromThe Jackson Laboratories, Bar Harbor, ME,
maintained under conventional conditions, and used at 8-9 wk of age .
Antibodies
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Materials and Methods
Rat mAb 14.8 (25, 26) was kindly provided by Dr . P . W . Kincade, Oklahoma Medical
Research Foundation, Oklahoma City, OK . Fluorescein isothiocyanate (FITC)-conjugated
goat anti-rat IgG (Cooper Biomedical Inc ., Malvern, PA) diluted 1 :10 in PBS, pH 7.2
(Gibco Laboratories, Grand Island, NY) was used as a second layer after cell surface
binding ofthe 14.8 antibody at 1 :20 dilution . Rabbit anti-TdT (Supertechs Inc ., Bethesda,
MD) was used at 1 :20 dilution with a rhodamine isothiocyanate (TRITC)-conjugated goat
anti-rabbit IgG F(ab') 2 second layer (1 :20 dilution ; Jackson Immunoresearch Laboratories
Inc ., Mississauga, Ontario) . TRITC- and FITC-conjugated affinity-purified goat antibod-
ies to mouse P chains (Kirkegaard & Perry Laboratories, Gaithersburg, MD) (anti-/-
TRITC and anti-A-FITC) were diluted 1 :10 in PBS . All antibodies were centrifuged for
30 min in an Airfuge (Beckman Instruments, Palo Alto, CA) to remove aggregates just
before use.
Bone Marrow Cell Samples
Mice were killed by cervical dislocation . Both femoral shafts were flushed with 1 ml
cold Eagles' MEM, pH 7 .2, containing 10% (vol/vol) Millipore-filtered newborn calf
serum (MEM/NCS, Gibco Laboratories) . After thorough resuspension, large particles
were removed by sedimentation into 1 ml NCS for 5 min . The marrow cells were then
centrifuged through 1 ml NCS (7 min, 200 g, room temperature) and resuspended in 1
ml MEM/NCS . The nucleated cells recovered from two femurs were counted with an
electronic particle counter (model B ; Coulter Electronics, Hialeah, FL) .
Metaphase Arrest
Mice were given vincristine sulfate (Eli Lilly, Toronto, Ontario, Canada ; or Sigma
Chemical Co ., St . Louis, MO) i.p . in a dose of 1 mg/kg body weight to stop cells in446
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metaphase (8, 38) . For stathmokinetic studies, marrow cells were sampled from uninjected
mice, and at four precise intervals, from mice injected with vincristine at 7:00 a.m .
Immunofuorescence Labeling
Double labeling of 14.8 and u chains.
￿
To detect surface membrane 14.8 antigen, 100
Al of marrow cells (4 X 10' nucleated cells/ml) were incubated for 30 min on ice with 100
,ul of mAb 14.8 . The cells were washed twice by centrifugation (4 ° C, 10 min, 220 g)
through NCS, exposed to FITC-conjugated goat anti-rat IgG (30 min, 4° C), washed
twice through NCS, and resuspended in 1 ml 0.15 M NaCl, with 2.7 mM disodiumEDTA
(Fisher Scientific Co ., Fairlawn, NJ) and BSA (Gibco Laboratories), 5% (wt/vol) . In a
cytocentrifuge (Cytospin ; Shandon Southern Instrument Inc ., Sewickly, PA) samples of 4
X 105 cells were deposited (1,000 rpm, 5 min) onto glass slides previously coated by
centrifugation of 100 ,ul PBS/BSA 3% (wt/vol) (10 min, 2,000 rpm) . The samples were
quickly air-dried, fixed in precooled 5% (vol/vol) glacial acetic acid in absolute ethanol
for 12 min on ice, and then washed three times and overnight in fresh PBS at 4 °C .
Double labeling ofsurface and cytoplasmic u chains .
￿
Bone marrow cell suspensions were
incubated with anti-,u-FITC (30 min, 4°C) to label sp, then washed, cytocentrifuged,
fixed, and exposed to anti-P,-TRITC, thus labeling total u chains, including both cP and
SA (8) .
Double labeling of 14.8 and TdT .
￿
After surface 14.8 labeling, as described above, the
cells were cytocentrifuged, fixed with absolute methanol, and then stained with rabbit
anti-TdT (2 h, 4°C) followed by TRITC-conjugated goat anti-rabbit IgG F(ab') 2 (30
min, 4°C) .
Double labeling of k chains and TdT
￿
Bone marrow cells were cytocentrifuged, fixed
with 5% acetic acid in ethanol and then exposed to anti-y-FITC followed by anti-TdT
labeling, as described above .
Slide preparations were mounted in 90% (vol/vol) glycerol (Fisher Scientific Co .) in
PBS, pH 8 .0, containing 0 .1% (wt/vol) p-phenylenediamine (Fisher Scientific Co .) to
reduce fading of the fluorescein during microscopy (39) . An epifluorescence microscope
(Carl Zeiss ofCanada Ltd ., Don Mills, Ontario, Canada) equipped with a HBO 50 mercury
lamp, phase-contrast optics, and a X 100 oil-immersion phase-contrast objective was used
for analysis .
Immunofluorescence Analysis
Individual marrow cells were scored for (a) single labeling with either FITC alone
(14.8, sp) or TRITC alone (cA, TdT), or (b) double labeling with FITC plus TRITC (14.8
+cE, sj + cA,TdT + 14.8) . Fluorescing cells were examined by phase-contrast to measure
the cell diameter, using an eyepiece micrometer scale, and to detect cells in metaphase
arrest . The incidence of cu'sA pre-B cells, su ' B cells, 14.8+A cells, and 14 .8+,' cells, as
well as the proportion of 14.8+,- cells in metaphase (metaphase index, Imet) were derived
by examining at least 1,000 nucleated cells . The counts included at least 100 cells of each
of the four phenotypes and at least 20 14.8+,u cells in metaphase . The absolute number
ofmarrow B lineage cells was calculated from their incidence and the total bone marrow
cellularity . The incidences ofTdT+,u- , TdT+ 14.8+ , and TdT+ 14.8- cells were calculated
by examining more than 3,000 nucleated cells, including at least 100 cells of each of the
three phenotypes . To determine their size distribution, 300 TdT+ cells were measured
by ocular micrometer .
Results
Populations of 14.8+ Cells Lacking A Chains in Bone Marrow
Incidence .
￿
Approximately one-quarter of all the cells that bound the B lym-
phocyte lineage-associated mAb 14.8 in normal bone marrow lacked detectable
p chains either in the cytoplasm or at the cell surface (Table 1) . Such 14 .8+g-
cells represented ~5% of all the nucleated bone marrow cells or 8 X 105 cells4
3
v
0
a
U
G 2
O
O
w
O
U I
C
b
U
C
0
PARK AND OSMOND
TABLE I
Analysis of 14.8+ and A Chain-bearing B-lineage Cells in Mouse
Bone Marrow by Double Immunofuorescence Staining
* Means± SD ; n = 11 .
$ Double immunofluorescence labeling for surface binding of mAb 14.8
and for the presence of A chains (CA and sy).
$ Double immunofluorescence labeling for sA and for CA (±su) .
e 14.8' Cp S1i
. 14 .8+ Cp- Sp-
'
￿
14.8' Cy- Sy -
in metaphase
o TdT'
FIGURE 1 .
￿
Size distribution of cell populations bearing 14.8 antigen, either with or without
the simultaneous presence of A chains (CA + sW), and ofTdT+ cells in cytocentrifuge prepara-
tions of mouse bone marrow .
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per femoral shaft . On the other hand, the numbers of 14.8+ cells bearing ju
chains corresponded with those of pre-B cells (c,u+sA) plus B lymphocytes (sA''),
determined separately .
Size distribution .
￿
Measurements of cytocentrifuged 14.8+/A-cells showed them
to be mostly large cells, 7-16 Am in diameter with a single size distribution curve
and a modal value of 11 .5 Am (mean, 10.9 Am) (Fig . 1) . This contrasted with the
broad biphasic curve of A, chain-bearing 14.8' cells, 4.5-15 Am in diameter,
peaking at 8-9 Am and 11 .5 Am, representing small B lymphocytes and nondi-
viding pre-B cells, as well as large replicating pre-B cells (6, 8, 10). The 14.8+A
cells thus resembled closely the large proliferatingpre-B cells in size distribution .
Morphology. The largest 14.8+ta cells were undifferentiated blasts with a
circular, indented, or irregularly-shaped nucleus and copious cytoplasm; others
resembled large lymphoid cells with little cytoplasm and a circular or slightly
indented nucleus having a fine chromatin pattern.
14.8
Cell markers
CA sk
Incidence (percent
of total nucleated
cells)*
Actual number
(X 10-5)per
femur*
+ - - 5.2 1 1 .2$ 81 2
+ + + 17.0±2.21 27±4
+ - 10.9±1 .211 17±1 .8
+ 7.8 ± 0 .81 12 t 1 .244 8
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FIGURE 2 .
￿
Size distribution of 14.8'p cells arrested in metaphase, total 14.8'P_ cells, and
14.8'u' cells in mouse bone marrow 4 h after administering vincristine sulfate .
Mitoses.
￿
A few (2-4%) 14 .8+A cells were normally observed in mitosis by
phase-contrast microscopy . These cells were almost all larger than 10 Am diam-
eter (Fig . 1) .
Proliferative Dynamics of14.8 +,- Cells in Bone Marrow
14.8+A,- cells in vincristine-treated mice .
￿
To examine the kinetic properties of
14.8+,,- cells, vincristine sulfate was given in vivo . After 4 h, a large proportion
(40%) of the 14.8+A- cells had accumulated in metaphase arrest (Fig . 2), as
distinguished under phase-contrast by a characteristically condensed, irregular
chromosomal mass . The mitotic index increased with cell size, almost all the
largest 14.8+u- cells (>13 Am) having entered mitosis within 4 h after vincristine
administration . At the same time, the size distribution of the total 14 .8+A- cell
population shifted to the right, showing some decrease in smaller cells and
increase in larger cells in vincristine-treated mice (Fig . 2) relative to untreated
mice (Fig . 1) .
After vincristine treatment, the cellularity of the bone marrow declined to
83% of normal values by 4 h, while the 14 .8+t.- and 14.8+g+ cell populations
both fell to about 65% of normal values (Table 11), as previously noted for pre-
B cells (8) .
Rate of entry into mitosis and cell population turnover.
￿
Groups of mice were
examined at four time intervals from 2 to 4 h after vincristine administration
(Fig . 3) . The accumulation of 14.8+,,- bone marrow cells in metaphase followed
a linear curve throughout this period of time . Regression analysis and extrapo-
lation of the data indicated an initial lag time of 50 min before the vincristine
began to arrest 14.8+I- cells in metaphase (Fig . 3) . Thereafter, metaphases
accumulated at a rapid rate, representing the rate of entry of 14.8+A- cells into
mitosis, indicating a rapid turnover and a short apparent cell cycle time of cells
in this phenotypic compartment (Table 111) . Combined with the population size
(Table 1), these data revealed a high production rate, totalling 0 .4 X 108 14.8+J-
cells/d/mouse (Table 111) .PARK AND OSMOND
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TABLE II
14.8 +A- and 14.8+p+ Cells in Bone Marrow ofNormal and Vincristine-treated Mice
50
N 40
a> U
U
+CO 30
01
0
￿
I
￿
2
￿
3
Time after Vincristine ( h )
FIGURE 3 .
￿
Imet of 14.8+k bone marrow cells after vincristine. The curve was obtained by
linear regression analysis of the values forImet derivedfrom four groups of three mice given
vincristine .
Cell Populations Defined by TdT and 14.8 Antigen in Bone Marrow
Incidence .
￿
Cells showing a patchy intranuclear localization of TdT formed a
small but well-defined population, totalling 1.8% of all nucleated cells in normal
bone marrow. In double immunofluorescence labeling experiments, one-half of
the TdT' cells simultaneously expressed the 14.8 surface antigen (Table IV),
but of a sample of 200 TdT' cells, none had detectable A chains (cA or s/ .t) .
Size distribution .
￿
The TdT' cells as a whole were mainly medium-sized cells,
corresponding in diameter with the smaller cells of the 14.8+A population and
peaking at 10 Am (range, 7-13 Am ; mean, 9 .7 Am) (Figs . 1 and 4) . The TdT'
cells binding mAb 14.8 tended to be somewhat larger than those lacking 14 .8-
antigen, the size distribution curve of TdT+14.8' cells (peak and mean, 10 Am)
Mice
Experimental group n
Totalbone
marrow cellu-
larity per fe-
mur (X 10-s)
Normal 3 15.7
After vincristine
2 h 3 14.5
2 h, 40 min . 3 13.7
3 h, 20 min. 3 13 .4
4 h 3 13 .0
Total 15 14.1
Incidence (percent of
total nucleated cells)
Actual
10-5)
number (X
perfemur
14.8+,u- 14.8+W+ 14.8+k 14 .8+IA+
5.2 15.6 8.1 24.5
4.5 15 .1 6.6 21 .9
4.2 11 .3 5.8 15 .5
3.9 12.6 5.3 16.9
4.0 13.0 5 .3 15.6
4.4 13.5 6.2 18 .8450 EARLY B LYMPHOCYTES PRECURSORS IN BONE MARROW
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TABLE III
Kinetics of 14
.8',u - Bone Marrow Cells
Entry into mitosis*
Turnover time* (average apparent cell cycle time)
Number of cells produced per:
Femoral shaftl
Total bone marrow)
C3H/Hej d mice, 8-9-wk-old.
* Slope of line obtained by linear regression analysis of the Imet for 14.8*ta-
cellsafter vincristine (Fig. 3).
Turnover time = 100/rate ofentry into mitosis.
¢ Calculated as (number of cells per femur from Table I) X (0.01) X (rate of
entry into mitosis).
n Calculated as (cells produced perfemur) X 15.8 X 24 h. 15.8 is the conversion
factor forone femurto whole-body bone marrow (8).
TABLE IV
Expression of TdT and 14.8 Antigen by ThreePopulations of
Presumptive Early B Lymphocyte Precursor Cells in Bone Marrow
* Analyzed by double immunofluorescence labeling for nuclear TdT and
forsurface binding of mAb 14.8.
*Calculated by subtracting values for TdT'14.8' cells from those of
14.8'
￿
cells (Table I).
Parameter
13.5%/h
7.4 h
"--" TdT 14.8
" -" TdT*14.8'
Value
1.1 X 105 cells/h
410 X 105 cells/d
9 r 10 T 12
￿
14 15
Cell diameter (pm )
FIGURE 4.
￿
Size distribution of cells bearing TdT and 14.8 antigen in normal mouse bone
marrow.
being consistently shifted slightly to the right of that of TdT+14 .8- cells (peak,
9 Am ; mean, 9.5 Am) (Fig. 4) .
Mitoses.
￿
Some mitotic cells were observed to have detectable TdT dispersed
throughout the cytoplasm.
Group
TdT
Phenotype
14.8 CA
Incidence (percent
of total nucleated
cells)
Actual number
(X 105) per
femur
1 + - - 0.9±0.2* 1.4±0.3
2 + + - 0.9±0.2* 1.4±0.3
3 - + - 4.3±0.3$ 6.6±0.44) u
v
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FIGURE 5 .
￿
Size distribution of TdT-14.8'W cells in normal mouse bone marrow (derived
by subtracting data for TdT'14.8'A cells [Fig . 41 from those for total 14.8'A cells [Fig . 11) .
14.8+ Cell Population Lacking TdTand A Chains in Bone Marrow
The foregoing data demonstratethat thepopulation of 14.8+A cells in normal
bone marrow (Fig . 1, Table 1) includes a subset of TdT+ cells (Fig . 4, Table IV) .
By subtracting values forTdT+14.8+ cells, all of which were demonstrated to be
lacking A chains, from those for 14.8+,u- cells, a population ofTdT-14.8+k cells
could be defined with respect to incidence (Table IV) and diameter (Fig. 5) .
These cells represented the larger 14.8+A cells and showed a single, sharp size-
distribution curve (peak, 11 .5 Am ; mean, 11 .7 Am) (Fig . 5) .
Three Populations ofPresumptive EarlyB Lymphocyte Precursors in Bone
Marrow
Three phenotypically distinct subsets of cells have thus been identified by
double immunofluorescence labeling for the expression of TdT and 14.8 in the
absence of detectable 1 chains (TdT+14.8-, TdT+14.8+, and TdT-14 .8+), as
summarized in Table IV and Figs . 4 and 5 .
Discussion
Using cytological markers, the present work defines three subsets of cells in
mouse bone marrow, putatively representing steps in the development of early
B lymphocyte precursors before the synthesis of j heavy chains . These cells,
which would include the phase ofA heavy chain gene rearrangement, have now
been shown to be in active cell cycle, and their normal production rate has been
quantitated in vivo . The work provides a working model of the phenotype and
proliferation of early B cell progenitors, and raises questions concerning the
potential effect of cellular events at this stage of development on the number
and size ofB cell clones ultimately delivered to the immune system .
Cells that bind the B lineage-associated mAb 14.8 but lack A heavy chains
form a substantial population in mouse bone marrow . Accounting for ^-5% of
all nucleated bone marrow cells, such 14.8+A cells are 1 .5 times as numerous as452
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the large proliferative cA +sA - pre-B cells, previously quantitated in the same
mouse strain (8) . The population size of 14.8+A,- cells determined in the present
work by double immunolabeling accords with values that can be derived from
the reported incidences of 14.8+ cells and of K+ cells, measured separately (26) .
In the latter reports, using a different mouse strain (CBA), with lowerfrequencies
of pre-B cells, the numbersof 14 .8+, .- cells, wouldbe equivalent to approximately
one to two times those of all pre-B cells (26) . From its magnitude alone, the
14.8+, .- cell compartment would appear likely to represent the major population
of pre-,u chain precursor cells in mouse bone marrow .
The present findings now demonstrate an active proliferation of B precursor
cells after they first express 14.8 antigen and before developing cj,. Essentially
the whole population of 14.8+/A- cells appears to be in cell cycle, as suggested by
the shape of its size distribution curve as well as the shift in size from small to
large 14.8+,u- cells during metaphase arrest, a finding that reflects the continuing
growth of cells in interphase not being replaced by the usual production of small
postmitotic cells . The rate of accumulation of metaphases during mitotic arrest
indicates a turnover time and mean cell cycle time of 7.4 h for 14.8+/" cells.
Both the size distribution profile and cell cycle time of 14.8',u cells resemble
closely those we have observed previously for the large proliferating subset of
c,+s,- pre-B cells (8).
The effects of mitotic arrest on the 14.8+ ,u- cell population suggest that the
developmental boundaries marking the beginning and end of this compartment
do not coincide with the mitotic phase of the cell cycle . During mitotic arrest, as
well as their shift in size distribution, the 14.8+Ec- cells in femoral marrow show
a progressive drop in absolute number . This phenomenon could be due to three
factors. First, it could be a toxic effect . The dose of vincristine used, however,
was well within the nontoxic range established for proliferating large pre-B cells
in mouse bone marrow (8), and the rate of accumulation of mitosis remained
linear over the 4-h period ofobservation . Vincristine toxicity, on the otherhand,
causes a decline or plateau in the accumulation of mitoses after a few hours.
Second, a decline in cell number after vincristine will occur if the population
consists of a mixture of dividing and nondividing cells. As the proliferating cells
accumulate in mitosis, inflow from proliferating cells ofthe precedingphenotypic
compartment ceases, yet the nondividing cells continue progressively to develop
the features ofthe next phenotypic compartment and are thus perceived as being
lost from the compartment under study . Such is the case for the population of
c,+sA- pre-B cells (8) . After vincristine, the small pre-B cells decline in number
as they continue to develop su without cell division and pass from the pre-B cell
to B lymphocyte compartment . In the present work, the 17% decline in total
cellularityof thebonemarrow after vincristine reflects the continuing emigration
and loss of nondividing end cells during the arrest of their proliferating precur-
sors . The 14 .8+Fc- cells, however, as already noted, are probably all in cell cycle.
The third possibility is that the phenotypic transition from one compartment to
the next occurs some hours after the last mitosis within a completely cycling
compartment. The postmitotic cells in early interphase at the onset of mitotic
arrest continue to leave the compartment for some hours as they develop thePARK AND OSMOND
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phenotypic markers of the next differentiation stage. Because the number of
cells within a given compartment doubles in successive generations, the loss of
postmitotic cells will exceed any input from the preceding compartment over the
same period of time . The latter explanation fits all the observed data for the
14.8+A- cell population, suggesting that the cells first express w heavy chains
during interphase at least 3 h after the beginning of cell cycle . This would mark
the point of transition from the 14.8+A cell to the ct+
sh
- pre-B cell stage.
Quantitation of the proliferation of 14 .8+A cells in vivo, calculated from their
observed number and turnover time, indicates a total turnover of 0.4 X 108
cells/d throughout the entire bone marrow . This value represents the total
turnover of cells within the 14 .8+A cell compartment itself. It is not clear,
however, whether this value represents cells passing either concurrently through
a single cell cycle or sequentially through two or more cell cycles . The number
of successive cell generations of 14 .8+A cells will determine the degree of cellular
expansion within the compartment and the relationship between the calculated
turnover of 14.8+ucellsand thenumber of cells flowingfrom this developmental
stage per unit time . If the calculated turnover represents a single cell cycle, the
progeny ofdividing cells will leave thecompartment at twice this rate . In contrast,
if each 14.8+A cell undergoes multiple cell cycles, the cells in the final generation
will number only approximately half of the total 14.8+tL- cells, and the calculated
turnover of the whole population will approximate the actual outflow from the
compartment . The rate at which cells need to enter the compartment to maintain
the steady state may be only a small fraction of this . Thus, the present study
suggests that the production of cells leaving the 14.8+A compartment is in the
range of 0.4-0.8 X 108 cells/d, depending on the number of generations within
the phenotypic compartment. This number is not known . The rate of fall in
number of 14 .8+AL- cells after vincristine suggests that the ratio of outflowing
cells to inflowing cells is greater than would be the case if only a single cell
division had occurred . In vitro maturation assays of bone marrow depleted of
14.8+A` cells (11, 25, 26) as well as a precursor B cell cloning assay in vitro (40)
also accord with the possibility of more than one cell cycle within the 14 .8+AL-
phenotype . More direct indications are required of the number of generations
of 14.8+A- cells and thus the total time spent and the overall expansion achieved
by cells entering this phenotypic compartment in vivo .
A small but well-defined subset of u- lymphoid cells in mouse bone marrow
exhibits intranuclear TdT. TheseTdT+ cellsappear to be mainly B-lineage cells,
including the stage of Ig heavy chain gene rearrangement . The present work
reveals that half of the TdT+ cells in mouse bone marrow also express the B
lineage-associated antigen, 14.8 . Depletion studies suggest that this antigen is
expressed by virtually all the immediate precursors of B lymphocytes (11, 25,
26) . Furthermore, some cells transformed by infection with the Abelson murine
leukemia virus are 14.8+A cells showing Ig heavy chain gene rearrangement
(11) . Human and rat bone marrow also contain small subsets of TdT+ cells (28,
32, 37, 41) which normally coexpress various B lineage-associated antigens (35,
37) . In addition,TdT has been detected in human pre-B cell leukemias (42, 43),
and in a few normal pre-B cells in human subjects (35) and C57BL/6 mice (44) .454
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FIGURE 6.
￿
Incidence and size distribution of A-bearing B-lineage cells (sm' B lymphocytes;
cA'sA pre-B cells) and A candidate B lineage cells (14.8'TdT- cells ; TdT'14 .8- and
TdT'14.8' cells) in mousebone marrow .
FIGURE 7.
￿
Scheme of differentiation ofB lymphocytes in mouse bone marrow,
TdT itself has recently been implicated as the enzyme catalyzing the insertion of
additional nucleotide sequences, the N regions, at thejunctions of Ig heavy chain
gene segments, one mechanism of immunological diversification (33, 34). The
presence of TdT would therefore provide a cellular marker of the stage of Ig
heavy chain gene rearrangement . It has yet to be shown, however, whether the
presence of either TdT or 14.8 antigen is an obligatory step in B cell genesis .
Unlike Ig, neither the 14.8 antigen nor TdT in the bone marrow are neces-
sarily entirely specific for the B cell lineage . The 14.8 antigen is expressed in
small amounts on a subset of peripheral T lymphocytes (25, 26) . TdT character-
izes immature lymphocytes of both B andT lineages . TdT' cells can be induced
to appear in bone marrow cultures by thymic hormones (45), and bone marrow
cultures can show high incidences of TdT' cells lacking both B and T lineage
markers (46) . Thus, it cannot be excluded that some TdT+ cells in bone marrow
may be prethymic T cell precursors or other undifferentiated lymphoid cells .
Based on the expression ofTdT and 14 .8 antigen, threephenotypically distinct
subsets of j .- cellscan be distinguished as presumptive early B lineage precursors .
Fig . 6 compares both their incidenceand size distribution with thoseof previouslyPARK AND OSMOND
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defined B lymphocyte lineage populations . In Fig . 7, these subsets of cells are
depicted in a scheme of B lymphocyte differentiation, proposing a sequential
expression of TdT, 14 .8 antigen, and cu by individual cells . This scheme
represents the simplest interpretation consistent with the present data and
provides a model for testing the precursor-product relationships of the cell
subsets now described .
The demonstration of a mitotic stepand of the presence ofTdT at the 14.8+A
stage of B lymphocyte development, in addition to the proliferative phase
previously noted in large pre-B cells (6, 8), are important in considering the
number of different clones ofB cellsand the number ofcells per clone potentially
available for delivery to the immune system . The present kinetic data also suggest
that the total production of 14.8+A cells is somewhat in excess of that of
previously calculated for large pre-B cells (8), thus pointing to some cell loss,
possibly reflecting ineffective gene rearrangements at this stage . The phenotypes
and proliferation rates now established for candidate precursor cells in normal
bone marrow form the basis for continuing work on perturbations and the
factors which normally regulate primary B cell production in vivo .
Summary
Bone marrow cells were examined by double immunofluorescent labeling
techniques to detect determinants for the B lineage monoclonal antibody, 14.8,
the nuclear enzyme, terminal deoxynucleotidyl transferase (TdT), cytoplasmic j
chains (cu), and surface u (su) . In 8-9-wk-old C3H/Hej mice, 14.8' cells totalled
22.2% of all marrow cells (35 X 105 cells/femur). While many 14 .8' cells were
cu+su- pre-B cells and su+ B lymphocytes (17 .0%), the remainder (5.2%) were
large cells lacking A chains . After injecting vincristine sulfate, these 14.8+tt- cells
accumulated in mitosis at a rate of 13.5%/h (turnover time, 7 .4 h) . Their
calculated total production rate (41 X 106 cells/whole marrow/d) exceeded that
previously determined for large pre-B cells, suggesting some cell loss from the B
lineage . TdT' cells made up 1 .8% of marrow cells and were mainly medium-
sized cells . They all lacked 1 chains, but half (0.9%) bound 14 .8 antibody at low
to medium intensity . Three discrete cell populations were thus defined, differing
in mean cell diameter (a) TdT+ 14.8-,u , 9.5 um ; (b) TdT''14.8+A-, 10 um ; and
(c) TdT- 14.8'A , 11 .5 um, presumptively representing a sequence of cell stages
preceding the expression of u chains in large pre-B cells (TdT- I4.8*cu''su- , 11 .5
um) . This work provides a tentative model of early progenitor cells and their
proliferation in normal marrow as a basis for studies of perturbations and the
control of B lymphocytopoiesis .
The technical assistance of Ms . Jenny W . L . Eng, Ms . Lyne Bourbonniere and Dr . Hoon
Lee is gratefully acknowledged .
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